Analysed IDORSIA LTD (IDRSF:OTCMKTS) News Sources
Efficacy of aprocitentan in patients across the cardiometabolic disease spectrum including obesity to be presented at AHA Hypertension
05-10-2026
yahoo.com
New results across pediatric, adult and real-world insomnia settings highlight the expanding clinical evidence for daridorexant at Sleep Europe 2026
08-10-2026
yahoo.com
Aprocitentan efficacy data reinforce endothelin pathway blockade as a distinct therapeutic approach across the cardiometabolic disease spectrum including obesity
12-10-2026
yahoo.com
Idorsia presents outstanding results with daridorexant in children and adolescents with insomnia and an expanding body of evidence in adults at Sleep Europe 2026
23-10-2026
yahoo.com
A new scientific avenue for daridorexant: Idorsia to advance development in autism spectrum disorder
26-10-2026
yahoo.com
Idorsia seeks US label update for QUVIVIQ daytime functioning benefits – first patients enrolled in Dari-Dream
27-10-2026
yahoo.com
Idorsia initiates pivotal Phase 3 study for lucerastat in Fabry disease and enters co-development and commercialization agreement with Nxera
28-10-2026
yahoo.com
Nxera Pharma Secures Exclusive Rights to Fabry Disease Phase 3 Oral Therapy Candidate Lucerastat for Japan and Selected Asia Pacific Markets
28-10-2026
yahoo.com
Idorsia and SPV investors partner to unlock the blockbuster potential of TRYVIO/JERAYGO with a targeted launch in specialists
29-10-2026
yahoo.com
What is the current price of IDORSIA LTD (IDRSF:OTCMKTS)?
The current price of IDORSIA LTD (IDRSF:OTCMKTS) is $4.95.
IDORSIA LTD (IDRSF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of IDORSIA LTD (IDRSF:OTCMKTS) since the previous trading day is $-0.43.
IDORSIA LTD (IDRSF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of IDORSIA LTD (IDRSF:OTCMKTS) since the previous trading day is -7.9926%.
What is the most recent average sentiment score for IDORSIA LTD (IDRSF:OTCMKTS)?
The most recent average sentiment score for IDORSIA LTD (IDRSF:OTCMKTS) is 73 out of 100.
What is the most recent average sentiment for IDORSIA LTD (IDRSF:OTCMKTS)?
The most recent sentiment for IDORSIA LTD (IDRSF:OTCMKTS) is .
SEC-8K** Filing Available For IDORSIA LTD (IDRSF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.